SCHEMBL6130101

SCHEMBL6130101

c1ccc(-c2ccc(COc3ccccn3)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.58
ALDH1A1 P00352 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C19 P33261 1/20 0.58
IDO1 P14902 2/20 0.50
AGXT P21549 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
GABRA5 P31644 1/20 0.50
SMPD1 P17405 1/20 0.47
GSTP1 P09211 1/20 0.46
FFAR1 O14842 1/20 0.44
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
GRM5 P41594 2/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A3 Q01959 1/20 0.43
ADAMTS4 O75173 1/20 0.42
LTA4H P09960 1/20 0.42
MAPK14 Q16539 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10055039 0.90 NPC1 (0.68) NPC1ALDH1A1CYP2D6CYP2C19GABRA5
SCHEMBL29816629 0.88 ALDH1A1 (0.61) NPC1ALDH1A1CYP2D6CYP2C19IDO1
SCHEMBL223680 0.88 ALDH1A1 (0.61) NPC1ALDH1A1CYP2D6CYP2C19IDO1
Formaldehyde SCHEMBL29285221 0.83 CYP2C19 (0.56) NPC1ALDH1A1CYP2D6CYP2C19GABRA5
SCHEMBL510167 0.81 NPC1 (0.58) NPC1ALDH1A1CYP2D6CYP2C19GABRA5
SCHEMBL510090 0.81 NPC1 (0.63) NPC1ALDH1A1CYP2D6CYP2C19GABRA5
SCHEMBL510400 0.81 NPC1 (0.58) NPC1ALDH1A1CYP2D6CYP2C19IDO1
SCHEMBL21054861 0.81 NPC1 (0.58) NPC1ALDH1A1CYP2D6CYP2C19GABRA5
SCHEMBL31544077 0.81 NPC1 (0.63) NPC1ALDH1A1CYP2D6CYP2C19GABRA5
SCHEMBL18429765 0.81 NPC1 (0.58) NPC1ALDH1A1CYP2D6CYP2C19IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1389105-A4 METHOD OF TREATMENT MERCK & CO INC (US) 2005-08-17 EP claimed
EP-1389105-A1 METHOD OF TREATMENT Merck & Co., Inc. (US) 2004-02-18 EP claimed
WO-2002092081-A1 METHOD OF TREATMENT MERCK & CO., INC. (US) 2002-11-21 WO claimed
US-5185340-A Angiotensin II antagonists AMERICAN HOME PRODUCTS CORPORATION (US) 1993-02-09 US disclosed